VectivBio Holding AG (VECT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    VectivBio Holding AG

    NASDAQ: VECT · Real-Time Price · USD
    16.87
    0.02 (0.12%)
    At close: Jul 07, 2023, 9:59 PM

    VectivBio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 27.34M n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 27.34M n/a
    Operating Income
    		 -80.52M -86.72M
    Interest Income
    		 676K n/a
    Pretax Income
    		 -93.63M -86.94M
    Net Income
    		 -93.73M -87.01M
    Selling & General & Admin
    		 33.91M 35.81M
    Research & Development
    		 73.95M 50.18M
    Other Expenses
    		 n/a 729K
    Operating Expenses
    		 107.86M 86.72M
    Interest Expense
    		 3.16M 36K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 107.86M 86.72M
    Income Tax Expense
    		 107K 64K
    Shares Outstanding (Basic)
    		 44.13M 26.96M
    Shares Outstanding (Diluted)
    		 44.13M 26.96M
    EPS (Basic)
    		 -2.12 -3.23
    EPS (Diluted)
    		 -2.12 -3.23
    EBITDA
    		 -79.85M -86.41M
    EBIT
    		 -90.46M -86.87M
    Depreciation & Amortization
    		 676K 303K

    Add to Watchlist